FDA Warning Letter — Exxon

Case 521770 — FEI 3013395224

The FDA took a Warning Letter action against Exxon on Apr 6, 2017 (Baltimore, MD). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Exxon
Date
Apr 6, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Baltimore, MD (United States)